MEGA PROJECT

MEGA PROJECT

Pharmaceutical Hydrogenation for World-Scale Green H2 in NEOM

Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. NEOM hosts the world's largest planned green hydrogen facility, targeting 600 tonnes per day of green hydrogen for conversion to green ammonia.

Local Brief

NEOM

Industry Focus

World-Scale Green H2Green Ammonia ExportSolar-Wind HybridDesalination

0.1

Ω·cm²

350

μm

3x

Lower

Logistics

Air freight from India to NEOM (via Tabuk) in 3-5 business days

Ultra-Clean Hydrogen Source

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

GMP-Compatible On-Site Generation

On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.

Batch-Flexible Operation

Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.

Pharmaceutical Hydrogenation in NEOM

NEOM hosts the world's largest planned green hydrogen facility, targeting 600 tonnes per day of green hydrogen for conversion to green ammonia. The project combines massive solar and wind generation with GW-scale electrolysis, representing the single largest opportunity for AWE membrane deployment globally.

At NEOM scale, membrane efficiency is not a marginal consideration but a project-defining variable. IONZERA's 3x lower resistance across the thousands of cells required for GW-scale production translates to hundreds of millions in lifecycle electricity cost reduction. India's proximity to NEOM (3-5 day delivery) provides supply chain advantages.

World-Scale Green H2Green Ammonia ExportSolar-Wind HybridDesalination
20%

Thinner Profile

3x

Lower Resistance

TECHNICAL ADVANTAGE

IONZERA Performance for NEOM

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

Membrane Thickness

20% THINNER
Membrane Thickness ComparisonIONZERA350-410 μmZirfon500 μm500 μm scale20-30%thinnerThinner membrane = More compact stacks= Higher power density

Frequently Asked Questions

Can I get IONZERA pharmaceutical hydrogenation membranes in NEOM?

Yes. G-Hexa ships IONZERA membranes to NEOM, Saudi Arabia. Air freight from India to NEOM (via Tabuk) in 3-5 business days

Why use IONZERA for pharmaceutical hydrogenation in NEOM?

IONZERA delivers 3x lower ionic resistance than Zirfon, reducing cell voltage and electricity costs for pharmaceutical hydrogenation applications. At NEOM scale, membrane efficiency is not a marginal consideration but a project-defining variable.

What is NEOM's green hydrogen production target?

NEOM targets 600 tonnes per day of green hydrogen, converted to green ammonia for export. This requires GW-scale electrolysis capacity, creating massive demand for high-performance AWE membranes.

Ready to Start

Request Pharmaceutical Hydrogenation Samples for NEOM

Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples and technical support for your NEOM project.

Request Sample